Ashley Booth argues for renewed psychedelic research, reviewing LSD and psilocybin relief of cluster headaches, MAPS’s MDMA-assisted psychotherapy for PTSD, and ibogaine treatment for opiate addiction. She discusses why off-patent, single-use drugs attract no pharmaceutical development, the Controlled Substances Act’s research barriers, and her Aware Project’s events and monthly salons.
This summary was generated with the help of AI from the talk's transcript. Corrections welcome.
More from BIL:Los Angeles 2015
- (Underwater) Citizen Science — Kachina Gosselin ▶ video
- Biomimicry and Innovation Inspired by Sharks — Colin Mangham ▶ video
- Bring It to The World and Beyond — Alex Lightman ▶ video
- Citizen Journalism — Andrew McGregor ▶ video
More on Mind & Consciousness
- "Cyborg: Space, Kybernetes, Ship, Man, State, Art, Craft" — Ross Bochnek
- 2012 - "The world is not going to end" ancient wisdom modern times — Brian David Hardin
- A Mind-Full of Pause Moments — Linzi Martin
- A New Basic Human Skill — Richard Gordon